https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:34159 -8; AUC: 0.909, CR: 72.7%). Conclusions: These results support the use of expression profiling in whole blood in the absence of more specific tissue types for investigations of metabolic disease. Using a pathway analysis approach it was possible to identify an enrichment of DEG into biological pathways that could be targeted for in vitro follow-up.]]> Wed 15 Dec 2021 16:10:14 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:50314 Tue 18 Jul 2023 11:37:22 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45231 Thu 27 Oct 2022 12:56:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48011 + memory T cells were the predominant sources of interleukin (IL)-4 and IL-13 transcripts whose expressions were dexamethasone resistant. Production of IL-13 by these cells was validated by IL-13-reporter mice. Neutralization of IL-13 abolished HDM/LPS-induced airway hyperresponsiveness, airway inflammation, and decreased mucus hypersecretion. Furthermore, using Ingenuity Pathway Analysis systems, we identified canonical pathways and upstream regulators that regulate the activation of basophils, ILC2, and CD8⁺ memory T cells. Our study provides mechanistic insights and an important reference resource for further understanding of the immune landscape during asthma exacerbation.]]> Thu 23 Mar 2023 10:07:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:56016 Thu 18 Jul 2024 09:34:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:6615 Sat 24 Mar 2018 07:46:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:35863 Mon 16 Dec 2019 16:25:28 AEDT ]]>